TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32924947

Group type: EXPERIMENTAL
Intervention: Facemask wearing in the workplace
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Facemask wearing in other public settings
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Hand sanitizing
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Avoiding social/meal gatherings
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Avoiding crowded places
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Knowledge about COVID-19
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived risk of COVID-19
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived severity of COVID-19
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived effectiveness of individual preventive measures
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived effectiveness of organizational preventive measures
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived effectiveness of governmental preventive measures
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Perceived preparedness for potential outbreak after work resumption
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Exposure to COVID-19 specific information through official media channels
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Face-to-face communication regarding COVID-19
Number of subjects: 3035

Group type: EXPERIMENTAL
Intervention: Number of preventive measures implemented within workplace
Number of subjects: 3035
Study: 36122608

Group type: EXPERIMENTAL
Intervention: IoT‐assisted TIGER
Number of subjects: 18

Group type: COMPARATOR
Intervention: TSMT
Number of subjects: 18
Study: 33038685

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback group, n = 11
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group, n = 12
Number of subjects: 23
Study: 33141770

Group type: EXPERIMENTAL
Intervention: No prophylactic antibiotic therapy
Number of subjects: 268
Study: 32345383

Group type: EXPERIMENTAL
Intervention: New equation for estimating 24-h urinary Na excretion from casual spot urine specimen
Number of subjects: 807

Group type: COMPARATOR
Intervention: INTERSALT method
Number of subjects: 807

Group type: COMPARATOR
Intervention: Kawasaki method
Number of subjects: 807
Study: 35320659

Group type: EXPERIMENTAL
Intervention: Third dose of BNT162b2 vaccine
Number of subjects: 10125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10125
Study: 33468507

Group type: EXPERIMENTAL
Intervention: Metronomic chemotherapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 34312662

Group type: EXPERIMENTAL
Intervention: Brain plasticity-based computerized cognitive training programme
Number of subjects: 83

Group type: COMPARATOR
Intervention: Active control (computer games)
Number of subjects: 83
Study: 33230550

Group type: EXPERIMENTAL
Intervention: bOPV at birth, 6, and 10 weeks, bOPV+IPV at week 14, IPV at week 18
Number of subjects: 572

Group type: COMPARATOR
Intervention: IPV at 6, 10, and 14 weeks, bOPV at 18 weeks
Number of subjects: 572
Study: 33200489

Group type: EXPERIMENTAL
Intervention: Fosmetpantotenate (300 mg oral dose three times daily)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Fosmetpantotenate
Number of subjects: 84
Study: 36206511

Group type: EXPERIMENTAL
Intervention: Knee flexed to approximately 90°
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fully extended position (control)
Number of subjects: 32
Study: 33228992

Group type: EXPERIMENTAL
Intervention: IDMQ J-aggregates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free state IDMQ
Number of subjects: 0
Study: 32887379

Group type: EXPERIMENTAL
Intervention: Capsinoid (9 mg/day) for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Capsinoid (9 mg/day) for 6 weeks in overweight subgroup
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 6 weeks in overweight subgroup
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Capsinoid (9 mg/day)
Number of subjects: 40
Study: 35751657

Group type: EXPERIMENTAL
Intervention: Midostaurin with concomitant strong CYP3A4 inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: High midostaurin plasma exposure
Number of subjects: 0
Study: 32389735

Group type: EXPERIMENTAL
Intervention: Gabapentin (single dose preoperatively)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control (acetaminophen and celecoxib alone)
Number of subjects: 129
Study: 32772826

Group type: EXPERIMENTAL
Intervention: 3 mg or 10 mg of melatonin
Number of subjects: 62
Study: 35441908

Group type: EXPERIMENTAL
Intervention: Secret Agent Society (SAS)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 89
Study: 33637368

Group type: EXPERIMENTAL
Intervention: Test/motivational interviewing group
Number of subjects: 174

Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 174
Study: 32020185

Group type: EXPERIMENTAL
Intervention: ISG15 secreted from HT29 cells and primary 3D colonoids through JAK1-pSTAT-IRF9-dependent and independent pathways.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TLR3 and TNF treatment of human IECs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human peripheral blood mononuclear cells (PBMCs) treated with ISG15.
Number of subjects: 0
Study: 35060609

Group type: EXPERIMENTAL
Intervention: UMC+CC (Usual Medical Care plus Chiropractic Care)
Number of subjects: 750

Group type: COMPARATOR
Intervention: UMC (Usual Medical Care)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: UMC+CC
Number of subjects: 750

Group type: COMPARATOR
Intervention: UMC
Number of subjects: 750
Study: 34085117

Group type: EXPERIMENTAL
Intervention: Prone position PCNL
Number of subjects: 200

Group type: COMPARATOR
Intervention: Flank position PCNL
Number of subjects: 200
Study: 34605384

Group type: EXPERIMENTAL
Intervention: Peer support group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dietician-led support group
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Minimal support group
Number of subjects: 75

Group type: COMPARATOR
Intervention: All participants
Number of subjects: 75
Study: 32219719

Group type: EXPERIMENTAL
Intervention: C. albicans from HVS samples
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 20 randomly selected resistant isolates
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Isolate RPCA9
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Isolate RPCA61
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: HVS isolates RPCA 21, RPCA 22, and RPCA 44
Number of subjects: 228
Study: 33310502

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (monotherapy with selective serotonin reuptake inhibitors, SSRI, or selective serotonin noradrenalin reuptake inhibitors, SSNRI)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Psychotherapy (interpersonal psychotherapy)
Number of subjects: 38
Study: 32899492

Group type: EXPERIMENTAL
Intervention: Red wine intervention (250 mL of wine/day, 4 weeks)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 11
Study: 35014192

Group type: EXPERIMENTAL
Intervention: Toothbrush plus interdental brushes (group TB/IDB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Toothbrush plus rubber interdental picks (group TB/RIDB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothbrush (group TB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothbrush plus dental floss (group TB/F)
Number of subjects: 0
Study: 33596623

Group type: COMPARATOR
Intervention: Alcohol Assisted Photorefractive Keratectomy (AAPRK)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Transepithelial Photorefractive Keratectomy (TPRK)
Number of subjects: 29
Study: 35317615

Group type: EXPERIMENTAL
Intervention: Ticagrelor + Aspirin
Number of subjects: 1169

Group type: COMPARATOR
Intervention: Ticagrelor + Placebo
Number of subjects: 1169
Study: 32036679

Group type: EXPERIMENTAL
Intervention: Mobile phone-based peer support (MPPS) intervention
Number of subjects: 16
Study: 35979784

Group type: EXPERIMENTAL
Intervention: TiRobot‐assisted operation (trial group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Traditional manual operation (control group)
Number of subjects: 74
Study: 32564705

Group type: EXPERIMENTAL
Intervention: Polyurethane peripherally inserted central catheters (n = 17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hydrophobic peripherally inserted central catheters (n = 15)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Dwell time
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Catheter design (biomaterial)
Number of subjects: 32
Study: 35943328

Group type: EXPERIMENTAL
Intervention: Fasting (16 h overnight fasting)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Re-feeding
Number of subjects: 50
Study: 33573861

Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical prostatectomy (RARP)
Number of subjects: 782

Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 782
Study: 35929135

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytoreductive surgery (CRS) alone
Number of subjects: 0
Study: 32706122

Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin A (BoNT‐A) injections
Number of subjects: 57

Group type: COMPARATOR
Intervention: Two‐duct ligation of the submandibular glands
Number of subjects: 57
Study: 34089749

Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulator (SimBaby™, Laerdal)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Low-cost (LC) simulator (inert infant manikin with SimBaby™ software)
Number of subjects: 128
Study: 33128677

Group type: EXPERIMENTAL
Intervention: Genetically predicted PCOS
Number of subjects: 122977
Study: 32960827

Group type: EXPERIMENTAL
Intervention: Oral glutathione (reduced glutathione) daily for 24 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 33886440

Group type: EXPERIMENTAL
Intervention: Restaurant owners identified as lesbians
Number of subjects: 1406

Group type: EXPERIMENTAL
Intervention: Restaurant owners identified as gay
Number of subjects: 1406

Group type: EXPERIMENTAL
Intervention: Increase in the number of women among the owners
Number of subjects: 1406
Study: 34049350

Group type: EXPERIMENTAL
Intervention: Rebound tonometry (RT, ic100)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Goldmann tonometry
Number of subjects: 72
Study: 32022604

Group type: EXPERIMENTAL
Intervention: Bilingual children
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Multilingual children
Number of subjects: 90

Group type: COMPARATOR
Intervention: Monolingual children
Number of subjects: 90
Study: 35186959

Group type: EXPERIMENTAL
Intervention: α-Lipoic acid (ALA) 1200 mg/d, intravenous infusion once daily plus standard care
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care plus equal volume saline infusion (placebo)
Number of subjects: 17
Study: 35107113

Group type: EXPERIMENTAL
Intervention: 2 g day-1 of GP seasoning
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no seasoning consumed)
Number of subjects: 29
Study: 34461664

Group type: EXPERIMENTAL
Intervention: G_Game (supervised pelvic floor muscle training through gametherapy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: G_Control (unsupervised pelvic floor muscle training)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: G_Game
Number of subjects: 20
Study: 35179770

Group type: EXPERIMENTAL
Intervention: Persian barley water (PBW) 250 ml daily for two weeks
Number of subjects: 100
Study: 34167596

Group type: EXPERIMENTAL
Intervention: Sweet breakfast (cereal with sucralose)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-sweet breakfast (plain cereal)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups (regardless of exposure)
Number of subjects: 54
Study: 34816454

Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 0
Study: 34334656

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (chemo ± radiation)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Surgery only (control group)
Number of subjects: 130
Study: 33880943

Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Decoupling (DC)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Decoupling in sensu (DC-is)
Number of subjects: 113
Study: 32902313

Group type: EXPERIMENTAL
Intervention: FamTechCare video support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control telephone support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expert feedback from FamTechCare intervention
Number of subjects: 0
Study: 36376952

Group type: EXPERIMENTAL
Intervention: 3D personalized insoles in addition to traditional rehabilitation (bracing and exercises)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional rehabilitation (bracing and exercises)
Number of subjects: 36
Study: 34904467

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily for 8 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo daily for 8 weeks
Number of subjects: 80
Study: 35321653

Group type: EXPERIMENTAL
Intervention: Stryker insufflator (STR) group
Number of subjects: 200

Group type: COMPARATOR
Intervention: Storz insufflator (STO) group
Number of subjects: 200
Study: 34464524

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy for Preventing Suicide Behavior (MBCT-S)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Enhanced treatment-as-usual (eTAU)
Number of subjects: 140
Study: 34430347

Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2) + pemetrexed (500 mg/m2) + bevacizumab (15 mg/kg) (CisPemBev)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Carboplatin (AUC 6 mg/mL/min) + paclitaxel (200 mg/m2) + bevacizumab (15 mg/kg) (CarPacBev)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: CisPemBev
Number of subjects: 199

Group type: COMPARATOR
Intervention: CarPacBev
Number of subjects: 199
Study: 34964239

Group type: EXPERIMENTAL
Intervention: Direct resin composite post and core (CP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Multiple fiber posts and resin composite core (FP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CAD/CAM anatomical post and core (AP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Metal cast post and core (MP)
Number of subjects: 48
Study: 34183558

Group type: EXPERIMENTAL
Intervention: Lateral orbital wall decompression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-wall procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lateral wall decompression alone
Number of subjects: 0
Study: 33031713

Group type: EXPERIMENTAL
Intervention: CMR-guided fibrosis ablation plus pulmonary vein isolation (PVI)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Pulmonary vein isolation (PVI) alone
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: CMR-guided fibrosis ablation plus PVI
Number of subjects: 155
Study: 35975917

Group type: EXPERIMENTAL
Intervention: Extended-Release Naltrexone (XR-NTX)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Buprenorphine (BUP-NX)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: OUD pharmacotherapy
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Study medication
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Study medication duration
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Abstinent weeks
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Time to relapse
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Hispanic ethnicity
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Rating (HAM-D) score
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Baseline sedative use
Number of subjects: 428
Study: 33964907

Group type: EXPERIMENTAL
Intervention: Single 6 ml Hylan G-F 20 injection
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 35804407

Group type: EXPERIMENTAL
Intervention: Person-centred care (PCC) implementation
Number of subjects: 66
Study: 32326980

Group type: EXPERIMENTAL
Intervention: Smartphone-based digital cognitive behavioural therapy (CBT) intervention
Number of subjects: 242

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 242
Study: 34996968

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional dressing (non-NPWT)
Number of subjects: 30
Study: 33435733

Group type: EXPERIMENTAL
Intervention: ProCore needle (22-gauge)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard needle (22-gauge)
Number of subjects: 100
Study: 36243034

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LBI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard bupivacaine (0.50% with 1:200,000 epinephrine)
Number of subjects: 30
Study: 32968968

Group type: EXPERIMENTAL
Intervention: Group A (n = 60) - returned to simulation lab at 3 and 6 months
Number of subjects: 118

Group type: COMPARATOR
Intervention: Group B (n = 58) - returned to simulation lab only at 6 months
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Group A (n = 60) - retested at 3 months
Number of subjects: 118
Study: 32826624

Group type: EXPERIMENTAL
Intervention: Muscular tissue oxygen saturation-guided care
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Blood pressure management with nicardipine
Number of subjects: 800
Study: 35266971

Group type: EXPERIMENTAL
Intervention: Participants who screened positive for depression
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Lower MCS score (worse depression)
Number of subjects: 535

Group type: COMPARATOR
Intervention: Inflammatory markers (cytokines in tears and HLA‐DR expression by conjunctival surface cells)
Number of subjects: 535
Study: 34560012

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (10 mg orally twice daily for 12 weeks) plus high-dose dexamethasone (40 mg/day intravenously for 4 consecutive days)
Number of subjects: 132

Group type: COMPARATOR
Intervention: High-dose dexamethasone alone (40 mg/day intravenously for 4 consecutive days)
Number of subjects: 132
Study: 35713247

Group type: EXPERIMENTAL
Intervention: PDRN treatment (two consecutive injections of PDRN one and two days after surgery)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: PDRN treatment
Number of subjects: 44
Study: 32989176

Group type: EXPERIMENTAL
Intervention: beta-lactolin
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 36069668

Group type: EXPERIMENTAL
Intervention: Active tDCS (1.5 mA, 15 min, bilateral left anodal/right cathodal DLPFC, 2 sessions per week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 32
Study: 34807494

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.5 mg/kg bolus followed by 0.25 mg·kg−1·h−1 infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (equivalent dose and regimen to ketamine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study: 33487035

Group type: COMPARATOR
Intervention: High dose vitamin D supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zinc supplementation
Number of subjects: 0
Study: 32751788

Group type: EXPERIMENTAL
Intervention: XL-CAS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mi-CAS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ca-CAS
Number of subjects: 15
Study: 36056331

Group type: EXPERIMENTAL
Intervention: Introductory ultrasound course
Number of subjects: 20

Group type: COMPARATOR
Intervention: No additional education (control group)
Number of subjects: 20
Study: 32676136

Group type: EXPERIMENTAL
Intervention: Pulpotomy with mineral trioxide aggregate (PMTA)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Pulpotomy with calcium-enriched mixture (PCEM)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Root canal therapy (RCT)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: All treatments (PMTA, PCEM, RCT)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Preoperative pain factors
Number of subjects: 550
Study: 35523749

Group type: EXPERIMENTAL
Intervention: Ropivacaine combined with dexmedetomidine (group RD)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Ropivacaine combined with sufentanil (group RS)
Number of subjects: 160
Study: 33297825

Group type: EXPERIMENTAL
Intervention: Poor nutritional outcomes (cases)
Number of subjects: 678

Group type: COMPARATOR
Intervention: Qualitative data
Number of subjects: 678
Study: 36295619

Group type: EXPERIMENTAL
Intervention: Laser micro-grooved (LMG) platform switched implants and abutments (I&A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (non-diabetic)
Number of subjects: 16
Study: 33639440

Group type: EXPERIMENTAL
Intervention: Dual-task intervention
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Memory recall without a dual-task (‘recall only’)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No task (control group)
Number of subjects: 76
Study: 32972777

Group type: EXPERIMENTAL
Intervention: TI with transparency
Number of subjects: 30

Group type: COMPARATOR
Intervention: TI without transparency
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard 3D rendering
Number of subjects: 30
Study: 35795613

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with floating acupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Acupuncture (control group)
Number of subjects: 68
Study: 33218839

Group type: EXPERIMENTAL
Intervention: B-mode
Number of subjects: 1203

Group type: EXPERIMENTAL
Intervention: B-mode plus color Doppler
Number of subjects: 1203
Study: 32319154

Group type: EXPERIMENTAL
Intervention: Bespoke smoking cessation (BSC) package offered up to 12 individual sessions with a mental health smoking cessation practitioner
Number of subjects: 526

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 526